Literature DB >> 24695695

Dorsal root ganglion neurons carrying a P301S Tau mutation: a valid in vitro model for screening drugs against tauopathies?

Niels Alberts1, Karlijn Groen, Lisette Klein, Marek J Konieczny, Mandy Koopman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24695695      PMCID： PMC6802723          DOI： 10.1523/JNEUROSCI.0135-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  11 in total

1.  Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.

Authors:  Kunie Ando; Karelle Leroy; Céline Héraud; Zehra Yilmaz; Michèle Authelet; Valèrie Suain; Robert De Decker; Jean-Pierre Brion
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  Inhibition of tau aggregation in cell models of tauopathy.

Authors:  Inna Khlistunova; Marcus Pickhardt; Jacek Biernat; Yipeng Wang; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Curr Alzheimer Res       Date:  2007-12       Impact factor: 3.498

3.  Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.

Authors:  David Baglietto-Vargas; Masashi Kitazawa; Elaine J Le; Tatiana Estrada-Hernandez; Carlos J Rodriguez-Ortiz; Rodrigo Medeiros; Kim N Green; Frank M LaFerla
Journal:  Neurobiol Dis       Date:  2013-10-29       Impact factor: 5.996

4.  Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.

Authors:  Bridget Allen; Esther Ingram; Masaki Takao; Michael J Smith; Ross Jakes; Kanwar Virdee; Hirotaka Yoshida; Max Holzer; Molly Craxton; Piers C Emson; Cristiana Atzori; Antonio Migheli; R Anthony Crowther; Bernardino Ghetti; Maria Grazia Spillantini; Michel Goedert
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

5.  In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.

Authors:  Sandra Stoppelkamp; Helen S Bell; Jon Palacios-Filardo; Derryck A Shewan; Gernot Riedel; Bettina Platt
Journal:  Exp Neurol       Date:  2011-02-02       Impact factor: 5.330

6.  Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.

Authors:  Kelly Zhao; Giulia Ippolito; Lulu Wang; Valerie Price; Mi Hwa Kim; Gavin Cornwell; Stephanie Fulenchek; Gail A Breen; Warren J Goux; Santosh R D'Mello
Journal:  J Neurosci Res       Date:  2010-11-15       Impact factor: 4.164

Review 7.  Alzheimer disease therapy--moving from amyloid-β to tau.

Authors:  Ezio Giacobini; Gabriel Gold
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

Review 8.  Tau pathology and neurodegeneration.

Authors:  Maria Grazia Spillantini; Michel Goedert
Journal:  Lancet Neurol       Date:  2013-06       Impact factor: 44.182

9.  Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells.

Authors:  Helen Fong; Chengzhong Wang; Johanna Knoferle; David Walker; Maureen E Balestra; Leslie M Tong; Laura Leung; Karen L Ring; William W Seeley; Anna Karydas; Mihir A Kshirsagar; Adam L Boxer; Kenneth S Kosik; Bruce L Miller; Yadong Huang
Journal:  Stem Cell Reports       Date:  2013-08-29       Impact factor: 7.765

10.  Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.

Authors:  Manuela Mellone; Dimitra Kestoras; Melissa R Andrews; Elisa Dassie; R Anthony Crowther; Gorazd B Stokin; Jon Tinsley; Graeme Horne; Michel Goedert; Aviva M Tolkovsky; Maria Grazia Spillantini
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167
View more
  1 in total

1.  Tau protein function: The mechanical exploration of axonal transport disorder caused by persistent pressure in dorsal root ganglia.

Authors:  Lei Zhang; Jun Fu; Xin-Hua Cheng; Li Tang
Journal:  Mol Genet Genomic Med       Date:  2019-01-29       Impact factor: 2.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.